Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.59 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.55 |
| ▸ | OGG1 | O15527 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17973414 | 0.94 | HAO1 (0.66) | GSK3BHAO1HDAC1HDAC8HDAC3 | |
| SCHEMBL2003577 | 0.89 | KMT2A (0.52) | GSK3BHAO1CES1ALDH1A1KMT2A | |
| SCHEMBL1305020 | 0.86 | GSK3B (0.70) | GSK3BHAO1HDAC1HDAC8HDAC3 | |
| SCHEMBL6286372 | 0.81 | GSK3B (0.57) | GSK3BHAO1HDAC1HDAC8HDAC3 | |
| SCHEMBL6351346 | 0.80 | HSD17B3 (0.57) | ALDH1A1POLBCA1CA2HPGD | |
| SCHEMBL9754092 | 0.80 | TSHR (0.55) | CES1ALDH1A1KMT2AMEN1CA1 | |
| SCHEMBL3035986 | 0.80 | NPC1 (0.67) | GSK3BHDAC1HDAC6CES2CES1 | |
| SCHEMBL2635792 | 0.80 | HAO1 (0.63) | GSK3BHAO1HDAC1HDAC8HDAC3 | |
| SCHEMBL21202169 | 0.79 | GSK3B (0.55) | GSK3BHAO1HDAC1HDAC8HDAC3 | |
| SCHEMBL11827259 | 0.79 | GSK3B (0.55) | GSK3BHAO1HDAC1HDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119609119-B | Modification method of rare earth superfine nanowire, fluorescent ink, preparation method and application | 稀致远达(天津)新材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119609119-A | Modification method of rare earth superfine nanowire, fluorescent ink, preparation method and application | 稀致远达(天津)新材料有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-7067702-B2 | Process for preparing vinyl substituted beta-diketones | THE JOHNS HOPKINS UNIVERSITY (US) | 2006-06-27 | — | — | US | claimed |
| US-20060069288-A1 | Process for preparing vinyl substituted beta-diketones | THE JOHNS HOPKINS UNIVERSITY | 2006-03-30 | — | — | US | claimed |
| US-20250263394-A1 | COMPOUNDS, PREPARATION METHODS AND USES THEREOF | INVENTISBIO LLC | 2025-08-21 | — | — | US | disclosed |
| CN-119609119-B | Modification method of rare earth superfine nanowire, fluorescent ink, preparation method and application | 稀致远达(天津)新材料有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-119609119-A | Modification method of rare earth superfine nanowire, fluorescent ink, preparation method and application | 稀致远达(天津)新材料有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119095846-A | Compounds, methods of preparation and uses thereof | 益方生物科技(上海)股份有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-118271261-A | Dicarbonyl compound containing cyclobutane segment and synthesis method thereof | 中国科学技术大学 | 2024-07-02 | — | — | CN | disclosed |
| EP-4340056-A1 | POSITIVE ELECTRODE MIXTURE, POSITIVE ELECTRODE AND SECONDARY BATTERY | Daikin Industries, Ltd. (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-20240088381-A1 | POSITIVE ELECTRODE MIXTURE, POSITIVE ELECTRODE AND SECONDARY BATTERY | DAIKIN INDUSTRIES, LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| EP-4336584-A1 | POSITIVE ELECTRODE MIXTURE, POSITIVE ELECTRODE AND SECONDARY BATTERY | Daikin Industries, Ltd. (JP) | 2024-03-13 | — | — | EP | disclosed |
| EP-1416936-A1 | THIOPYRANE-4-ONES AS DNA PROTEIN KINASE INHIBITORS | Cancer Research Technology Limited (GB) | 2004-05-12 | — | — | EP | disclosed |
| WO-2003015790-A1 | THIOPYRANE-4-ONES AS DNA PROTEIN KINASE INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2003-02-27 | — | — | WO | disclosed |
| EP-0210284-B1 | 1,3-DITHIOL-2-YLIDENE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1992-08-19 | — | — | EP | disclosed |
| EP-0234480-A2 | 1, 3-diketone derivatives and their use | NIHON NOHYAKU CO., LTD. (JP) | 1987-09-02 | — | — | EP | disclosed |
| US-4668799-A | Anti-hepatitis and anti-cirrhotic 1,3-dithiol-2-ylidene derivatives, and pharmaceutical compositions therefor | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1987-05-26 | — | — | US | disclosed |
| EP-0210284-A1 | 1,3-Dithiol-2-ylidene derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1987-02-04 | — | — | EP | disclosed |
| EP-0168037-A2 | 1-6-Naphthyridin-2(1H)-ones useful as cardiotonics | STERLING DRUG INC. (US) | 1986-01-15 | — | — | EP | disclosed |
| US-4560691-A | 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation | STERLING DRUG INC. (US) | 1985-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263394-A1 | COMPOUNDS, PREPARATION METHODS AND USES THEREOF | PIK3CD, PIK3CA, PIK3C2B | GSK3B 127/4885HAO1 4598/4885HDAC1 451/4885 |
| US-20060069288-A1 | Process for preparing vinyl substituted beta-diketones | VRK1, VRK2, DEK | GSK3B 528/4885HAO1 835/4885HDAC1 4177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.